Sharechat Logo

NAB calls in $449.7M of high-yielding BNZ perpetual notes

Wednesday 20th February 2013

Text too small?

National Australia Bank is calling in $449.7 million of BNZ Income Securities perpetual shares which pay a coupon of 9.89 percent, the highest of any hybrid security traded on the NZX Debt Market.

The perpetual non-cumulative shares were issued on March 28, 2008, when prevailing interest rates were much higher. For example, New Zealand two-year swaps have tumbled more than 5 percentage points since then.

NAB is exercising its right to call the securities on their fifth anniversary and has asked NZX to halt trading in the shares between March 14 and the transfer date of March 28. They last traded at $1.01 per $1 face value, according to NZX.

The call leaves ANZ Bank New Zealand as the issuer of the hybrid with the highest coupon - 9.66 percent - also sold in 2008. Their first call date is April 18. ANZ spokesman Peter Barnao said last month that no decisions had been made yet on the perpetual bonds

ANZ last year called and repaid $350 million of subordinated bonds issued in 2007 with a coupon of 8.23 percent. BNZ also called $350 million of subordinated bonds sold in 2007 with a coupon of 8.42 percent.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report